SCHEMBL17445846

SCHEMBL17445846

CCNc1ccc(Br)cc1C(=O)NC/C=C/C(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 2/20 0.46
ALDH1A1 P00352 7/20 0.43
MAPT P10636 7/20 0.43
MEN1 O00255 5/20 0.43
LMNA P02545 5/20 0.43
POLB P06746 5/20 0.43
KMT2A Q03164 5/20 0.43
MCL1 Q07820 5/20 0.43
KDM4E B2RXH2 4/20 0.43
L3MBTL1 Q9Y468 4/20 0.43
RECQL P46063 3/20 0.43
HTT P42858 3/20 0.43
GAA P10253 3/20 0.43
BLM P54132 2/20 0.43
HPGD P15428 5/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
ALOX12 P18054 4/20 0.43
TP53 P04637 2/20 0.43
MAPK1 P28482 2/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18905207 0.81 ALDH1A1 (0.54) STAT3ALDH1A1MAPTMEN1LMNA
SCHEMBL17445804 0.81 KDM4E (0.44) ALDH1A1MAPTPOLBKDM4EGAA
SCHEMBL18596299 0.75 LMNA (0.42) ALDH1A1MAPTMEN1LMNAPOLB
SCHEMBL17445800 0.73 HPGD (0.49) ALDH1A1MAPTPOLBKMT2AKDM4E
SCHEMBL18988716 0.72 STAT3 (0.53) STAT3ALDH1A1MAPTMEN1LMNA
SCHEMBL17447412 0.71 HSD17B10 (0.52) ALDH1A1MAPTMEN1LMNAPOLB
SCHEMBL28247939 0.70 STAT3 (0.52) STAT3ALDH1A1MAPTMEN1LMNA
SCHEMBL13753947 0.69 HPGD (0.44) STAT3ALDH1A1MAPTMEN1LMNA
SCHEMBL13753955 0.68 MAPT (0.50) STAT3ALDH1A1MAPTMEN1LMNA
SCHEMBL17445840 0.68 SMN1; SMN2 (0.53) ALDH1A1MAPTMEN1LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170152228-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NORTHWESTERN UNIVERSITY (US) 2017-06-01 US disclosed
US-20170152228-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NORTHWESTERN UNIVERSITY (US) 2017-06-01 US disclosed
US-9586890-B2 Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods NORTHWESTERN UNIVERSITY (US) 2017-03-07 US disclosed
US-9586890-B2 Screening methods for the binding affinity of chemical entities to biological molecules and NEDD4-1 inhibitors identified by the screening methods NORTHWESTERN UNIVERSITY (US) 2017-03-07 US disclosed
US-20160016893-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NORTHWESTERN UNIVERSITY (US) 2016-01-21 US disclosed
US-20160016893-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NORTHWESTERN UNIVERSITY (US) 2016-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170152228-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NEDD4, STUB1, CUL1 STAT3 4109/4885ALDH1A1 1314/4885MAPT 3075/4885
US-20160016893-A1 SCREENING METHODS FOR THE BINDING AFFINITY OF CHEMICAL ENTITIES TO BIOLOGICAL MOLECULES AND NEDD4-1 INHIBITORS IDENTIFIED BY THE SCREENING METHODS NEDD4, STUB1, UBQLN1 STAT3 4334/4885ALDH1A1 2967/4885MAPT 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.